Development of artificial intelligence-assisted deprescribing chatbot for patients with cystic fibrosis discontinuing proton pump inhibitors
Background Supporting deprescribing of proton pump inhibitors (PPIs) is critical for patients with cystic fibrosis (CF), as long-term use may lead to adverse outcomes. Deprescribing barriers include patient access to healthcare providers (HCPs) and health information, as well as HCP time and knowled...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Health Literacy and Communication Open |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/28355245.2025.2536511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|